The first approved cholinesterase inhibitor drug was Tacrine (tetrahydroaminoacridine) for the treatment of Alzheimer’s disease symptoms, which increases ACh in neurons, but during several trials, it was found to have hepatotoxic effects [2,33]. Here, BCHE is linked to Alzheimer disease.